Schonfeld Strategic Advisors’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-169,710
| Closed | -$967K | – | 2019 |
|
|
2025
Q1 | $967K | Buy |
169,710
+67,829
| +67% | +$387K | 0.01% | 1204 |
|
|
2024
Q4 | $1M | Buy |
+101,881
| New | +$1M | 0.01% | 1060 |
|
|
2024
Q3 | – | Sell |
-14,449
| Closed | -$193K | – | 1957 |
|
|
2024
Q2 | $193K | Buy |
14,449
+12,600
| +681% | +$168K | ﹤0.01% | 1684 |
|
|
2024
Q1 | $85.8K | Buy |
+1,849
| New | +$85.8K | ﹤0.01% | 1677 |
|
|
2023
Q2 | – | Sell |
-498
| Closed | -$26.5K | – | 2057 |
|
|
2023
Q1 | $26.5K | Sell |
498
-13,372
| -96% | -$711K | ﹤0.01% | 1753 |
|
|
2022
Q4 | $938K | Buy |
13,870
+556
| +4% | +$37.6K | 0.01% | 1179 |
|
|
2022
Q3 | $1.66M | Buy |
13,314
+5,009
| +60% | +$625K | 0.01% | 961 |
|
|
2022
Q2 | $790K | Buy |
8,305
+6,800
| +452% | +$647K | 0.01% | 1055 |
|
|
2022
Q1 | $243K | Buy |
+1,505
| New | +$243K | ﹤0.01% | 1756 |
|